Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jacqueline Scanlan currently holds 68,695 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacqueline Scanlan has been a net seller of HAE stock. They have purchased $0 and sold $4.4M worth of shares.
Jacqueline Scanlan's most recent insider trade was on Feb 23, 2026, when they sold 1,404 shares at $14.62 per share.
Jacqueline Scanlan serves as Executive at HAEMONETICS CORP (HAE). They have executed 61 insider transactions totaling $4.4M over their tenure at the company.
Jacqueline Scanlan holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Jacqueline Scanlan has shown a selling trading pattern, with $0 in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jacqueline Scanlan was on Feb 20, 2024, when they purchased $977.3K worth of FMC shares. This transaction involved 19,167 shares at $50.99 per share.
Jacqueline Scanlan currently owns 68,695 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jacqueline Scanlan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jacqueline Scanlan has 61 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Jacqueline Scanlan and 40,000+ other insiders.